Corrigendum to “Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy”
Titel:
Corrigendum to “Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy”
Auteur:
Liu, S.V. De Braud, F. Drilon, A. Doebele, R.C. Patel, M.R. Cho, B.C. Ahn, M.J. Chiu, C.H. Farago, A.F. Goto, K. Lee, J. Ohe, Y. Ou, S.H.I. Cassier, P. Tan, D.S.W. Otterson, G.A. Veronese, L. Osborne, S. Simmons, B. Siena, S.